◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Zota Health Care Limited (ZOTA) Financial History

Name: Zota Health Care Limited (ZOTA) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-09-20

Zota Health Care Limited (ZOTA) operates in the Biotechnology industry and is headquartered in Surat, India with about 635 employees. Its market capitalization is roughly ₹40 billion. In the fiscal year ended 2026-03-31, ZOTA reported ₹5.4B in revenue and (₹739M) in net income.

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers pharmaceutical, nutraceutical, ayurvedic, and over-the-counter products. It also provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders.

Interactive charts & full statements →

ZOTA Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹5.4B	₹2.9B	₹1.8B	₹1.4B
Gross Profit	₹3.2B	₹1.5B	₹803M	₹551M
Operating Income (EBIT)	(₹641M)	(₹481M)	(₹126M)	(₹38M)
Net Income	(₹739M)	(₹564M)	(₹144M)	(₹58M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ZOTA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	₹1.7B	₹1.6B	₹1.4B	₹1.0B	₹973M
Gross Profit	₹1.1B	₹1.0B	₹862M	₹584M	₹494M
Operating Income (EBIT)	(₹394M)	(₹183M)	(₹227M)	(₹107M)	(₹118M)
Net Income	(₹436M)	(₹142M)	(₹295M)	(₹143M)	(₹129M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ZOTA Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹31M)	(₹27M)	(₹26M)	(₹38M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ZOTA Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹11.3B	₹4.4B	₹2.3B	₹1.6B	—
Total Liabilities	₹4.3B	₹2.1B	₹1.4B	₹778M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ZOTA viewer.

Other Companies in Biotechnology

MRNA · Moderna — $61 billion
6821 · Asymchem Laboratories (Tianjin) Co., Ltd. — HK$59 billion
3759 · Pharmaron Beijing Co., Ltd. — HK$54 billion
9995 · RemeGen Co., Ltd. — HK$44 billion
1530 · 3SBio Inc. — HK$39 billion
3696 · InSilico Medicine Cayman TopCo — HK$35 billion
2696 · Shanghai Henlius Biotech, Inc. — HK$33 billion
BIIB · Biogen — $32 billion

← ZOOZ All “Z” companies ZOYO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.